Lisa Drakeman

Article Abstract:

A US businesswoman Lisa Drakeman has blended goal-oriented American culture with a European focus on team effort to move her firm's antibodies closer to the market. Drakeman is establishing herself as business person in her own right, and antibodies as therapeutics, making believers out of once skeptical pharma companies.

United States, Executive changes & profiles, Officials and employees, Drakeman, Lisa

---

Company founders: voices of experience

Article Abstract:

The scientific founders play an important role in raising a company's scientific profile and in securing venture capitalist funding. Nine leading scientists who founded startup companies are revealing some common themes and lessons.

Research and Development in the Physical, Engineering, and Life Sciences, France, Norway, Scientists, Practice, ExonHit Therapeutics S.A., Affitech A/S

---

India's health biotech sector at a crossroads

Article Abstract:

The health biotech industry in India needs to develop research on the products relevant to domestic health. The detailed study of Indian health biotech industry and its efforts towards globalization is presented in the article.

Public affairs, India, Social aspects, Globalization

Similar abstracts:

• Abstracts: Diversify to multiply. A special biotech speculation. Splurge or merge?
• Abstracts: Canada's bumper biotech budget. Angel investors shy away from biotech
• Abstracts: Materials exchange deal meager boost to India's biotech. U.S. biodefense-shocking and awful. US food aid still under GM cloud
• Abstracts: Microarray reality checks in the context of a complex disease. High-affinity binders selected from designed ankyrin repeat protein libraries
• Abstracts: Where have all the antibiotic patents gone? Fishing for cancer models

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.